期刊文献+

结核分枝杆菌联合DNA疫苗初免—BCG加强的免疫效果观察 被引量:4

Immunogenicity of DNA vaccine prime-BCG boost against Mycobacterium tuberculosis
下载PDF
导出
摘要 目的:研究并比较结核分枝杆菌免疫保护性抗原DNA(Ag85A和ESAT-6)疫苗联合免疫,BCG免疫以及联合DNA疫苗初免—BCG加强免疫等不同的免疫策略,诱导免疫应答效果观察。方法:健康雌性BALB/c小鼠24只,随机分成PBS阴性对照组,DNA初免—BCG异源加强组,DNA(Ag85A和ESAT-6)初免DNA同源加强组和BCG阳性对照组,共进行3次免疫,初免2次,最后1次加强,间隔2周1次。PBS组3次均注射PBS溶液;DNA/BCG组以质粒DNA免疫2次,最后1次以BCG加强免疫;DNA/DNA组3次均以质粒DNA进行免疫;BCG组则注射PBS溶液2次后以BCG免疫。末次免疫后4、6、8周分别分离血清测定总IgG水平,同时分离小鼠脾细胞,体外经TB-PPD刺激后进行淋巴细胞增殖实验(XTT法)并测定脾细胞培养上清中IFN-γ和IL-4水平。结果:DNA/BCG、DNA/DNA、BCG组体外经TB-PPD刺激后均检测到特异性IgG抗体产生,3组平均效价为1∶120、1∶160、1∶80,DNA/DNA组的抗体效价高于另外2组;小鼠脾细胞体外经TB-PPD刺激后,均能产生特异性淋巴细胞增殖并诱生较强的IFN-γ反应,其中DNA/BCG组IFN-γ的分泌水平高于DNA/DNA组和BCG组(P<0.05)。结论:联合DNA疫苗初免—BCG加强的免疫策略能在小鼠体内诱导较强的特异性细胞免疫反应,产生高水平的IFN-γ。 AIM: To compare the immunogenicity of vaccine strategies about combined DNA prime-BCG boost and DNA or BCG vaccination only. METHODS: BALB/c mice were divided into four groups each containing 6 mice, and all mice received three immunizations at 2 weeks interval. One group of mice was vaccinated with PBS (PBS group) ; one group was vaccinated twice at 0 week and 2 weeks with combined DNA expressing two mycobactedal antigens, ESAT-6 and antigen 85A respectively; and then boosted with BCG at 4 weeks ( DNA/BCG group) ; another group was vaccinated twice with combined DNA at 0 week, 2 weeks and 4 weeks ( DNA/DNA group ) ; and the final group received PBS twice at 0 week and 2 weeks and then vaccinated with BCG at 4 weeks( BCG group). Specific IgG antibody in serum of mice was determined with indirect ELISA in 4 weeks, 6 weeks, 8 weeks respectively after final vaccination. The splenic lymphocytes of mice were separated and stimulated with PPD to measure their proliferation by XTT, and to evaluate the production of interferon-r(IFN-γ) and IL-4 in cell suspensions of spleen cells by ELISA. RESULTS: PPD could stimulate specific IgG responses in DNA/BCG, DNA/DNA and BCG groups ( DNA/DNA group 〉 DNA/BCG group and BCG group), and the most significant response occurred in 12 weeks; the splenic lymphocyte proliferation reactions and IFN-γ and IL-4 production was detectable in DNA/BCG, DNA/DNA and BCG groups and DNA/BCG group induced significant higher production, especially in 12 weeks. CONCLUSION: Pdming with the combined DNA vaccines and boost with attenuated M. bovis vaccine ( BCG ) could enhance specific cell reactions and high level IFN-γ compared with DNA or attenuated M. bovis vaccine alone.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2008年第2期122-125,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 四川省科技重点项目资助(03SG022-009) 教育部重点资助项目(104152)
关键词 结核分枝杆菌 AG85A ESAT-6 异源初免-加强免疫 Mycobacterium tuberculosis Ag85A ESAT-6 heterologous prime-boost strategy
  • 相关文献

参考文献10

  • 1Gurunathan S, Klinman DM, Seder RA. DNA vaccine : immunology, application, and optimization[J]. Ann Rev Immunol, 2000, 18:927 - 974.
  • 2龙洋,鲍朗,吴悦涵,赵明才,曾献武,张会东,朱庆平.结核分枝杆菌免疫优势抗原ESAT-6真核表达载体的构建及蛋白表达的鉴定[J].中国呼吸与危重监护杂志,2004,3(3):181-184. 被引量:4
  • 3张立群,马伟路,笪冀平.结核病小鼠病理学与T_H1/T_H2细胞动力学及iNOS表达关系的研究[J].中华微生物学和免疫学杂志,2001,21(2):166-170. 被引量:3
  • 4Buddle BM, Wedlock DN, Denis M. Progress in the development of tuberculosis vaccines for cattle and wildlife[ J]. Vet Microbiol, 2006, 112(2 -4) : 191 -200.
  • 5Skinner MA, Buddle BM, Wedlock DN, et al. A DNA pfime-Mycobacterium boris BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis [ J ]. Infect Immun, 2003, 71 ( 9 ) : 4901 - 4907.
  • 6Vordermeier HM, Rhodes SG, Dean G, et al. Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin [ J ]. Immunology, 2004, 112(3): 461 -470.
  • 7Kita Y, Tanaka T, Yoshida S, et al. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model [J]. Vaccine, 2005, 23( 17- 18): 2132-2135.
  • 8Grover A, Ahmed MF, Singh B, et al. A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens [ J ]. Microbes Infect, 2006, 8 ( 9 - 10 ) : 2390 - 2399.
  • 9Dhar N, Rao V, Tyagi AK. Immunogenicity of recombinant BCG vaccine strains over expressing components of the antige85 complex of Mycobacterium tuberculosis [ J ]. Med Microbiol Immunol, 2004, 193 ( 1 ) : 19 - 25.
  • 10Skeiky YA, Sadoff JC. Advances in tuberculosis vaccine strategies [J]. Nat Rev Microbiol, 2006, 6(4): 469-476.

二级参考文献17

  • 1万梅,凌亦凌.一氧化氮在肺内的代谢及其病理生理意义[J].国外医学(呼吸系统分册),1996,16(1):23-26. 被引量:7
  • 2谭明旗,魏路清,赵立,高云霞,谭朴泉.结核性及癌性胸膜炎患者血清及胸水可溶性白细胞介素2受体的研究[J].中国免疫学杂志,1997,13(2):127-128. 被引量:2
  • 3Lang B,Wei C,Huidong Z,et al.Virulence,Immunogenicity,and Protective Efficacy of Two Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Strains Expressing the Antigen ESAT-6 from Mycobacterium tuberculosis.Infect Immun,2003;71:1656~1661
  • 4Fine PE.Variation in protection by BCG:implications of and for heterologous immunity.Lancet,1995;346:1339-1345
  • 5Pym AS,Brodin P,Majlessi L,et al.Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.Nat Med,2003;9:533-539
  • 6Pym AS,Brodin P,Brosch R,et al.Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.Mol Microbiol,2002;46:709-717
  • 7Berthet FX,Rasmussen PB,Rosenkrands I,et al.A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10).Microbiology,1998;144:3195-3203
  • 8Cole ST,Brosch R,Parkhill J,et al.Deciphering the biology of Mycobacterium tuberculosis from the complet genome sequence. Nature,1998;393:537-544
  • 9Husson RN,James BE,Young RA.Gene replacement and expression of foreign DNA in Mycobacterium.J Bacteriol,1990;172:519-524
  • 10Mahairas GG,Sabo PJ,Hickey MJ,et al.Molecular analysis of genetic differences between Mycobacterium bovis BCG and avirulent M.bovis.J Bacteriol,1996;178:1274-1282

共引文献5

同被引文献28

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部